The role of surface learning neural network in the study of primary multiple breast cancer
- 29 June 2026
- journal article
- Published by "MedINK" Publishing House in Academy for Practical Oncology
- Vol. 1 (1)
Abstract
BACKGROUND: In recent decades, there has been an increase in the incidence of multiple malignancies. The incidence of this type of cancer ranges from 4.6 to 8.0 %. Subsequent tumors are detected between 1.5 and 42 years. The average interval between the primary and secondary processes is 6 years. More than 80 % of cases of primary multiple cancer (PMC) occur in people over 60 years of age. AIM: To generalize the patterns of development of PMC associated with breast cancer (BC), and to predict risk factors. METHODS: We retrospectively reviewed the medical records of 62 women with VUR, examined and treated at the Sverdlovsk Regional Oncology Center (Yekaterinburg) from 2020 to 2022. VUR associated with breast cancer was detected in 2 % of cases. Three women were excluded from the study according to the Warren–Gates criteria: two with metastases and one with mammary tuberculosis. The average time to secondary tumor detection was 5.4 years (range, 2 to 10 years). PMC was detected in the other breast in 29 % of cases, endometrial lesions were diagnosed in 17.7 % of patients, and malignant ovarian and renal neoplasms were diagnosed in 9.6 %. Disease progression in the form of metastases was observed in 14.5% of cases in patients over 55 years of age. Family history was a significant risk factor in 36 % of cases, gene mutations in 18.5 %, hormonal status in 49.4 %, obesity in 45.6 %, lymph node status in 48.4 %, previous treatment (chemotherapy or radiation therapy) in 5 %, and environmental factors in 24.5 %. A shallow learning neural network was used to predict risk factors for the development of PMC. The input data (diagnostic features) were converted to binary form: a value of “1” for a feature indicated its presence, a value of “0” indicated its absence. When training and testing the neural network, the target function was the time of secondary tumor onset and, in the presence of known breast cancer, also the time of progression. RESULTS: The risk of developing PMC within 5 years with a sensitivity of 86%, a specificity of 100 %, and an AUC of 0.929 (AUC – area under the receiver operating characteristic curve) was observed in patients over 60 years of age with stage T1–2N1 disease and luminal B and luminal/HER2-positive breast cancer (HER2 – human epidermal growth factor receptor 2). The development of PMC more than 5 years after the primary process, with a sensitivity of 64 %, a specificity of 86 %, and an AUC of 0.714, is possible in patients under 60 years of age with the luminal B molecular subtype of breast cancer and a primary tumor with a malignancy grade of G2. CONCLUSION: There is no consensus on the causes of PMC development (single tumors are not an exception). Increased survival after the onset of the first malignancy leads to an increased frequency of detection of second and subsequent tumors. Patients diagnosed with PMC, especially those with a strong family history and early onset of the disease, should be referred to a geneticist for consultation.Keywords
This publication has 23 references indexed in Scilit:
- Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testingESMO Open, 2025
- Genomic profiling of multiple breast cancer reveals inter-lesional heterogeneityBritish Journal of Cancer, 2020
- Incidence of second primary malignancy after breast cancer and related risk factors—Is breast‐conserving surgery safe? A nested case–control studyInternational Journal of Cancer, 2019
- Diet, menopause and the risk of ovarian, endometrial and breast cancerProceedings of the Nutrition Society, 2019
- Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatmentPharmacology & Therapeutics, 2018
- Impact of smoking on multiple primary cancers survival: a retrospective analysisClinical and Experimental Medicine, 2018
- The clinicopathological features of second primary cancer in patients with prior breast cancerMedicine, 2017
- Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patientsRadiotherapy and Oncology, 2015
- Multiple primary tumours in women following breast cancer, 1973–2000British Journal of Cancer, 2006
- Metachronous Triple Cancers of the Sigmoid Colon, Stomach, and Esophagus: Report of a CaseSurgery Today, 2000